Home LiteratureArticle Details
PMID: 12633661 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

T-cell responses of vaccinated cancer patients.

Current opinion in immunology ·Vol. 15 ·No. 2 ·2003-04-00 ·Pages 131-7

Coulie PG, van der Bruggen P

Abstract

Following vaccination with defined tumor antigens that are recognized by T cells, a small proportion of cancer patients display tumor regressions. Several reports describe anti-vaccine T-cell responses, evaluated with a variety of methods, for example, by assessing T-cell function or expression of specific TCR. However, a correlation between these T-cell responses and the tumor regressions has not yet been established. It appears that some patients display tumor regression with an unexpectedly low frequency of anti-vaccine T cells.

MeSH Terms
Antigens, Neoplasm/immunology Cancer Vaccines/genetics,therapeutic use Dendritic Cells/immunology Gene Expression Regulation, Neoplastic Humans Melanoma/drug therapy,genetics,immunology Monitoring, Immunologic/methods Neoplasm Proteins/immunology Receptors, Antigen, T-Cell/genetics T-Lymphocytes/drug effects,immunology Vaccination
Chemicals
Antigens, Neoplasm Cancer Vaccines MAGEA3 protein, human Neoplasm Proteins Receptors, Antigen, T-Cell
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Coulie Pierre G
Cellular Genetics Unit, Christian de Duve Institute of Cellular Pathology, Université de Louvain, Avenue Hippocrate 74, UCL 7459, B-1200 Brussels, Belgium. [email protected]
van der Bruggen Pierre
Article Info
Journal
Current opinion in immunology
Abbr.
Curr Opin Immunol
ISSN
0952-7915
Published
2003-04-00
Pages
131-7
Language
English
Region
England
NLM ID
8900118
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]